OXIS Financials 07/16/2014 03:59:14 OXIS Internat
Post# of 325
Posted On: 07/16/2014 4:59:11 AM
OXIS Financials 07/16/2014 03:59:14
OXIS International, Inc.
Period Ending Dec 31, 2011 Dec 31, 2010
Total Revenue 26 11
Cost of Revenue 48 65
Gross Profit (22) (54)
Operating Expenses
Research and Development 17 179
Sales, General and Admin. 3,889 2,264
Non-Recurring Items - -
Other - -
Operating Income (3,928) (2,497)
Income From Continuing Operations
Add'l Income/Expense Items 784 15
Earnings Before Interest and Tax (3,144) (2,482)
Interest Expense 556 513
Earnings Before Tax (3,700) (2,995)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (3,700) (2,995)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (3,700) (2,995)
Preferred Stock and Other Adjustments - (23)
Net Income Applicable to Common Shareholders (3,700) (3,018)
OXIS International, Inc.
Period Ending Dec 31, 2011 Dec 31, 2010
Total Revenue 26 11
Cost of Revenue 48 65
Gross Profit (22) (54)
Operating Expenses
Research and Development 17 179
Sales, General and Admin. 3,889 2,264
Non-Recurring Items - -
Other - -
Operating Income (3,928) (2,497)
Income From Continuing Operations
Add'l Income/Expense Items 784 15
Earnings Before Interest and Tax (3,144) (2,482)
Interest Expense 556 513
Earnings Before Tax (3,700) (2,995)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (3,700) (2,995)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (3,700) (2,995)
Preferred Stock and Other Adjustments - (23)
Net Income Applicable to Common Shareholders (3,700) (3,018)
(0)
(0)GT Biopharma Inc. (OXISD) Stock Research Links
Scroll down for more posts ▼